2 medications in one tablet...BD
Speedel Holding Ltd (SWX: SPPN) announced that it is delighted by the FDA approval of a second product containing SPP100 (aliskiren) in the USA for the treatment of hypertension. The approval was announced by Novartis who is responsible for commercialisation of this first in class direct renin inhibitor.
Tekturna HCT® [1] (aliskiren and hydrochlorothiazide) has been approved by the US Food and Drug Administration as a single-tablet combination of two high blood pressure medicines - Tekturna® [2] (aliskiren), the first new type of high blood pressure medicine in more than a decade, and the diuretic hydrochlorothiazide (HCT)[3]
US Approval For SPP 100 Combined With Diuretic To Treat Hypertension
0 comments :
Post a Comment